Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients (2012)

  • Authors:
  • USP affiliated authors: CONDINO NETO, ANTONIO - ICB
  • USP Schools: ICB
  • DOI: 10.1007/s10875-011-9623-6
  • Subjects: IMUNOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10875-011-9623-6 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s10875-011-9623-6 (Fonte: Unpaywall API)

    Título do periódico: Journal of Clinical Immunology

    ISSN: 0271-9142,1573-2592



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Journal of Clinical Immunology

    ISSN: 0271-9142

    Citescore - 2017: 3.27

    SJR - 2017: 1.611

    SNIP - 2017: 1.055


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100078180PC ICB BMI SEP 2012
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CABRAL-MARQUES, Otavio; SCHIMKE, Lena-Friederike; PEREIRA, Paulo Vítor Soeiro; et al. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients. Journal of Clinical Immunology, Amsterdam, v. 32, n. 2, p. 212-220, 2012. Disponível em: < http://dx.doi.org/10.1007/s10875-011-9623-6 > DOI: 10.1007/s10875-011-9623-6.
    • APA

      Cabral-Marques, O., Schimke, L. -F., Pereira, P. V. S., Falcai, A., Oliveira, J. B. de, Hackett, M. J., et al. (2012). Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients. Journal of Clinical Immunology, 32( 2), 212-220. doi:10.1007/s10875-011-9623-6
    • NLM

      Cabral-Marques O, Schimke L-F, Pereira PVS, Falcai A, Oliveira JB de, Hackett MJ, Errante PR, Weber CW, Ferreira JF, Kuntze G, Rosário-Filho NA, Ochs HD, Torgerson TR, Carvalho BTC, Condino-Neto A. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients [Internet]. Journal of Clinical Immunology. 2012 ; 32( 2): 212-220.Available from: http://dx.doi.org/10.1007/s10875-011-9623-6
    • Vancouver

      Cabral-Marques O, Schimke L-F, Pereira PVS, Falcai A, Oliveira JB de, Hackett MJ, Errante PR, Weber CW, Ferreira JF, Kuntze G, Rosário-Filho NA, Ochs HD, Torgerson TR, Carvalho BTC, Condino-Neto A. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of Paracoccidioidomycosis and other unusual infections in Brazilian patients [Internet]. Journal of Clinical Immunology. 2012 ; 32( 2): 212-220.Available from: http://dx.doi.org/10.1007/s10875-011-9623-6

    Referências citadas na obra
    Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulacsy V, Chernyshova L, Chernyshov V, Bondarenko A, Maria Cortes Grimaldo R, Blancas-Galicia L, Madrigal Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bue M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Marodi L, Boisson-Dupuis S, Puel A, Casanova JL. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635–48.
    Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, Gumbleton M, Toulon A, Bodemer C, El-Baghdadi J, Whitters M, Paradis T, Brooks J, Collins M, Wolfman NM, Al-Muhsen S, Galicchio M, Abel L, Picard C, Casanova JL. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332:65–8.
    Ryan KR, Hong M, Arkwright PD, Gennery AR, Costigan C, Dominguez M, Denning D, McConnell V, Cant AJ, Abinun M, Spickett GP, Lilic D. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutaneous candidiasis with or without APECED. Clin Exp Immunol. 2008;154:406–14.
    Schimke K, Chubb SA, Davis WA, Davis TM. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis. 2010;212:321–6.
    Fuleihan R, Ramesh N, Geha RS. Role of CD40–CD40-ligand interaction in Ig-isotype switching. Curr Opin Immunol. 1993;5:963–7.
    Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 1993;259:990–3.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291–300.
    DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:541–3.
    Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90:2170–3.
    Hostoffer RW, Berger M, Clark HT, Schreiber JR. Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. Pediatrics. 1994;94:234–6.
    Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47–54.
    Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Och HD. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99:624–7.
    Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373–84.
    Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4:1–23.
    Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51. quiz 1052–1043.
    Notarangelo LD, Fischer A, Geha RS, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Hammartrom L, Nonoyama S, Ochs HD, Puck J, Roifman C, Seger R, Wedgwood J. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009;124:1161–78.
    Stavnezer J. Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol. 2011;32:194–201.
    Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421–34.
    Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7:575–6.
    Kraakman EM, Bontrop RE, Groenestein R, Jonker M, Haaijman JJ, t Hart BA. Characterization of the natural immune response of rhesus monkey CD4 + ve T cells to the bacterial antigen streptolysin O (SLO). J Med Primatol. 1995;24:306–12.
    Jo EK, Kim HS, Lee MY, Iseki M, Lee JH, Song CH, Park JK, Hwang TJ, Kook H. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea. J Korean Med Sci. 2002;17:116–20.
    Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010;51:561–70.
    Benard G, Duarte AJ. Paracoccidioidomycosis: a model for evaluation of the effects of human immunodeficiency virus infection on the natural history of endemic tropical diseases. Clin Infect Dis. 2000;31:1032–9.
    Moraes-Vasconcelos D, Grumach AS, Yamaguti A, Andrade ME, Fieschi C, de Beaucoudrey L, Casanova JL, Duarte AJ. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis. 2005;41:e31–37.
    Barrozo LV, Mendes RP, Marques SA, Benard G, Silva ME, Bagagli E. Climate and acute/subacute paracoccidioidomycosis in a hyper-endemic area in Brazil. Int J Epidemiol. 2009;38:1642–9.
    Shikanai-Yasuda MA, Telles Filho Fde Q, Mendes RP, Colombo AL, Moretti ML. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297–310.
    Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis epidemiological features of a 1,000-cases series from a hyperendemic area on the southeast of Brazil. Am J Trop Med Hyg. 2011;85:546–50.
    Rolon PA. Paracoccidioidomycosis: an epidemic in the Republic of Paraguay, the center of South America. Mycopathologia. 1976;59:67–80.
    McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A. Experimental murine paracoccidioidomycosis induced by the inhalation of conidia. J Med Vet Mycol. 1987;25:165–75.
    Morejon KM, Machado AA, Martinez R. Paracoccidioidomycosis in patients infected with and not infected with human immunodeficiency virus: a case–control study. Am J Trop Med Hyg. 2009;80:359–66.
    Bethlem EP, Capone D, Maranhao B, Carvalho CR, Wanke B. Paracoccidioidomycosis. Curr Opin Pulm Med. 1999;5:319–25.
    Ferreira MS. Paracoccidioidomycosis. Paediatr Respir Rev. 2009;10:161–5.
    Brummer E, Castaneda E, Restrepo A. Paracoccidioidomycosis: an update. Clin Microbiol Rev. 1993;6:89–117.
    Fonseca ER, Pardal PP, Severo LC. Paracoccidioidomycosis in children in Belem, Para. Rev Soc Bras Med Trop. 1999;32:31–3.
    Pereira PM, Akel PB, Lima LL, Kimura EN, Jalkh AP. Multifocal paracoccidioidomycosis: a diagnostic challenge due to late cutaneous manifestation. An Bras Dermatol. 2011;86:149–52.
    Brazao-Silva MT, Andrade MF, Franco T, Ribeiro RI, Silva Wdos S, Faria G, Faria PR, Cardoso SV, Loyola AM. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011;54:e189–195.
    Marques SA. Fungal infections of the mucous membrane. Dermatol Ther. 2010;23:243–50.
    Gasparetto EL, Liu CB, de Carvalho Neto A, Rogacheski E. Central nervous system paracoccidioidomycosis: imaging findings in 17 cases. J Comput Assist Tomogr. 2003;27:12–7.
    Goldani LZ. Gastrointestinal paracoccidioidomycosis: an overview. J Clin Gastroenterol. 2011;45:87–91.
    Odashiro AN, Odashiro PR, Fernandes PI, Leite LV, Odashiro M, Maloney S, Fernandes BF, Di Cesare S, Burnier Jr MN. Eyelid and conjunctival paracoccidioidomycosis simulating carcinoma. Int Ophthalmol. 2011;31:63–7.
    Costa DL, Dias-Melicio LA, Acorci MJ, Bordon AP, Tavian EG, Peracoli MT, Soares AM. Effect of interleukin-10 on the Paracoccidioides brasiliensis killing by gamma-interferon activated human neutrophils. Microbiol Immunol. 2007;51:73–80.
    Cabral Marques, O., C. Arslanian, R. Nalio Ramos, M. Morato, Paulo Vitor Soeiro, Sonia Jancar MD, Janaíra Fernandes Ferreira, Cristina Worm Weber, Gisele Kuntze, Nelson Augusto Rosario, Beatriz Tavares Costa Carvalho, Patricia Cruz Bergami-Santos, Mary J. Hackett, Hans D. Ochs, Troy R. Torgerson, Jose Alexandre Marzagão Barbuto, and Antonio Condino-Neto. Dendritic cells from X-linked Hyper IgM patients demonstrate defective responses to the fungal pathogens Candida albicans and Paracoccidioides brasiliensis. J Allergy Clin Immunol. 2011 (in press).
    Romani L. The T cell response against fungal infections. Curr Opin Immunol. 1997;9:484–90.
    Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–41. e1322; quiz 1342–1323.
    Banatvala N, Davies J, Kanariou M, Strobel S, Levinsky R, Morgan G. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Arch Dis Child. 1994;71:150–2.
    Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multi-drug-resistant Acinetobacter anitratus species in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policies. Ann Trop Paediatr. 2001;21:245–51.
    Omwandho CO, Gruessner SE, Tinneberg HR. Early pregnancy loss and neonatal deaths associated with Klebsiella pneumonia infection: a mini review of possible occupational health risk. Arch Gynecol Obstet. 2006;273:258–60.
    Soler-Palacin P, Margareto C, Llobet P, Asensio O, Hernandez M, Caragol I, Espanol T. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr). 2007;35:83–9.
    Jacobs ZD, Guajardo JR, Anderson KM. XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol. 2008;30:631–4.
    Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med. 2009;48:426–31.
    Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F, Klotman ME, Diaz GA. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003;34:70–4.
    Guerra-Maranhao MC, Costa-Carvalho BT, Nudelman V, Barros-Nunes P, Carneiro-Sampaio MM, Arslanian C, et al. Response to polysaccharide antigens in patients with ataxia-telangiectasia. J Pediatr (Rio J). 2006;82(2):132–6.